IL17A and ovarian carcinoma: Research on ovarian cancer patients has shown that tumor-accumulated Th17 cells may play antitumor roles by expressing a variety of cytokines, such as IL-17, inducing helper T lymphocyte 1 (Th1) cell-related chemokines and recruiting T cells to the tumor microenvironment (TME) (32).